Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer

NCT04792892 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT04792892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04792892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Lead sponsor
Sahlgrenska University Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2021
Completion date
April 1, 2035
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer